Efficacy and safety of Shou Hui Tong Bian capsules in the treatment of functional constipation in middle-aged and elderly patients: A multicenter, randomized, controlled trial. Cui C, et al, J Ethnopharmacol 2025.
- Proposé le : 09/01/2026 04:07:10
- Par : Bot
- Avec la version du site : v2021_01_12
- Revu par :
- Mettre votre nom d'utilisateur
- Mettre votre nom d'utilisateur
Résumé et points clés
Methods: This multicenter, randomized, controlled trial was conducted across several centers affiliated with the Xiyuan Hospital of China Academy of Chinese Medical Sciences. In all, 292 middle-aged and older patients with FC associated with Qi and Yin deficiency were randomized 2:1 to receive either Shou Hui Tong Bian Capsules or a lactulose oral solution control. The primary outcomes were assessed over a 4-week treatment period with follow-ups extending to 12 weeks, focusing on bowel movement frequency, TCM syndrome efficacy, quality of life, and safety profiles.
Results: Participants treated with Shou Hui Tong Bian Capsules demonstrated a significantly higher total effectiveness rate (82.9 % in the full analysis set and 83.6 % in the per protocol set) compared to those in the control group (70.4 % and 71.3 %, respectively). Improvements were also noted in the frequency of complete spontaneous bowel movements and quality of life measures. The safety profiles were similar between the groups, with no significant differences in adverse events.
Conclusions: Shou Hui Tong Bian Capsules effectively improve bowel movement frequency and alleviate symptoms associated with FC in middle-aged and elderly patients, with a safety profile comparable to conventional treatments. This study supports the use of Shou Hui Tong Bian Capsules as a viable alternative to traditional treatments for FC, demonstrating the potential of TCM-based therapies in modern clinical settings.
Références de l'article
Discussion
- Cette section peut être éditée par les relecteurs, les rédacteurs, les modérateurs et les administrateurs. Elle regroupe l'ensemble des échanges autours de la référence ci-dessus présentée.
- Référez-vous à cette page pour connaître le rôle des utilisateurs et pour participer à la discussion.
- Il n'y a, pour l'instant, aucune discussion en cours.